PIC Therapeutics

About:

PIC Therapeutics is a biotechnology company focused on transforming the treatment of cancer.

Website: https://www.pictherapeutics.com/

Top Investors: OrbiMed, Lumira Ventures, Advent Life Sciences, Harrington Discovery Institute at University Hospitals, Belinda Termeer

Description:

PIC Therapeutics is a biotechnology company focused on transforming the treatment of cancer through the selective modulation of oncogene translation. The company is modulating oncogene translation to dramatically improve cancer patient outcomes. Their precision-based therapeutics target the “master switch” of cancer signaling pathways, selectively blocking oncogene protein production by modulating the Pre-Initiation Complex (PIC) that drives their mRNA translation. Its selective approach has the potential to simultaneously modulate multiple oncogenic drivers leading to a powerful new generation of cancer-treating therapeutics. PIC Therapeutics was founded in 2016 and is headquartered in Natick, Massachusetts, United States.